Prudential Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Prudential Financial’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,200	Closed	-$26K	–	2683
2022 Q4	$26K	Hold	18,200	–	–	﹤0.01%	2553
2022 Q3	$41K	Hold	18,200	–	–	﹤0.01%	2575
2022 Q2	$38K	Buy	+18,200	New	+$45K	﹤0.01%	2585
2019 Q3	–	Sell	-10,541	Closed	-$36K	–	2485
2019 Q2	$36K	Hold	10,541	–	–	﹤0.01%	2437
2019 Q1	$29K	Sell	10,541 -1,288	-11%	-$4.22K	﹤0.01%	2416
2018 Q4	$33K	Buy	+11,829	New	+$38.7K	﹤0.01%	2345
2018 Q2	–	Sell	-35,120	Closed	-$192K	–	2472
2018 Q1	$192K	Sell	35,120 -42,980	-55%	-$303K	﹤0.01%	2260
2017 Q4	$637K	Sell	78,100 -8,200	-10%	-$78.3K	﹤0.01%	1954
2017 Q3	$904K	Sell	86,300 -4,250	-5%	-$47.2K	﹤0.01%	1869
2017 Q2	$1M	Buy	90,550 +72,720	+408%	+$678K	﹤0.01%	1839
2017 Q1	$149K	Buy	+17,830	New	+$126K	﹤0.01%	2265
2016 Q4	–	Sell	-19,130	Closed	-$97K	–	2382
2016 Q3	$97K	Buy	+19,130	New	+$114K	﹤0.01%	2276

Other funds holding ENZ

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Prudential Financial's ENZ Position: Q1 2023 in Review

Prudential Financial sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 18,200 shares — an estimated $26K sold.

Prudential Financial first reported a position in ENZ in Q3 2016 and held it in 12 quarters. The position peaked at $1M in Q2 2017. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

Prudential Financial reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
Prudential Financial sold 18,200 Enzo Biochem, Inc. shares in Q1 2023, an estimated $26K.
Prudential Financial first reported a position in Enzo Biochem, Inc. in Q3 2016 and held it in 12 quarters.
Prudential Financial's Enzo Biochem, Inc. position peaked at $1M in Q2 2017.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Prudential Financial's 13F filing for Q1 2023, filed 12 May 2023.